Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

China · Delayed Price · Currency is CNY

2.960

+0.040 (1.37%)

Sep 30, 2026, 3:04 PM CST

Market Cap	5.61B -14.2%
Revenue (ttm)	5.24B -10.1%
Net Income	112.68M +20.3%
EPS	0.06 +20.2%
Shares Out	1.90B
PE Ratio	49.84
Forward PE	n/a
Dividend	0.09 (3.04%)
Ex-Dividend Date	Sep 29, 2026

Volume	20,037,063
Open	2.960
Previous Close	2.920
Day's Range	2.920 - 2.980
52-Week Range	2.540 - 4.150
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological, and anti-infective drugs and medications. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1995

Employees 4,702

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002390

Full Company Profile

Financial Performance

In 2025, SHE:002390's revenue was 5.62 billion, a decrease of -6.84% compared to the previous year's 6.03 billion. Earnings were 120.29 million, an increase of 18.65%.

Financial Statements